Literature DB >> 24227200

Protease-mediated ectodomain shedding.

Peter Clark.   

Abstract

Ectodomain shedding is the proteolytic cleavage of cell surface proteins resulting in the loss of the extracellular domains. This mechanism is important in a variety of normal and pathological processes, including growth factor signalling, cell adhesion, inflammation and cell survival. Elevated protease activity in the lungs is a key pathological mechanism in emphysema which could enhance ectodomain shedding in lung cells. Here, the major steps and consequences of ectodomain shedding are reviewed. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ADAMs; emphysema; matrix metalloproteinase; secretase; sheddase

Mesh:

Substances:

Year:  2013        PMID: 24227200     DOI: 10.1136/thoraxjnl-2013-204403

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

Review 1.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

2.  Ectodomain cleavage of FLT1 regulates receptor activation and function and is not required for its downstream intracellular cleavage.

Authors:  Nandita S Raikwar; Kang Z Liu; Christie P Thomas
Journal:  Exp Cell Res       Date:  2016-03-23       Impact factor: 3.905

3.  A cytoplasmic C-terminal fragment of Syndecan-1 is generated by sequential proteolysis and antagonizes Syndecan-1 dependent lung tumor cell migration.

Authors:  Tobias Pasqualon; Jessica Pruessmeyer; Vera Jankowski; Aaron Babendreyer; Esther Groth; Julian Schumacher; Andrea Koenen; Sarah Weidenfeld; Nicole Schwarz; Bernd Denecke; Holger Jahr; Daniela Dreymueller; Joachim Jankowski; Andreas Ludwig
Journal:  Oncotarget       Date:  2015-10-13

4.  A key role of GARP in the immune suppressive tumor microenvironment.

Authors:  Susanne A Hahn; Annemarie Neuhoff; Jenny Landsberg; Jonathan Schupp; Daniela Eberts; Petra Leukel; Matthias Bros; Martin Weilbaecher; Detlef Schuppan; Stephan Grabbe; Thomas Tueting; Volker Lennerz; Clemens Sommer; Helmut Jonuleit; Andrea Tuettenberg
Journal:  Oncotarget       Date:  2016-07-12

5.  Tracking yeast pheromone receptor Ste2 endocytosis using fluorogen-activating protein tagging.

Authors:  Anita Emmerstorfer-Augustin; Christoph M Augustin; Shadi Shams; Jeremy Thorner
Journal:  Mol Biol Cell       Date:  2018-09-12       Impact factor: 4.138

Review 6.  Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator.

Authors:  Jingwei Bian; Zijian Li
Journal:  Acta Pharm Sin B       Date:  2020-10-13       Impact factor: 11.413

7.  Plasma levels and tissue expression of soluble TGFβrIII receptor in women with early-stage breast cancer and in healthy women: a prospective observational study.

Authors:  Lovorka Grgurevic; Ruder Novak; Vladimir Trkulja; Stela Hrkac; Grgur Salai; Josko Bilandzic; Lejla Ferhatovic Hamzic; Ivan Milas; Tiha Vucemilo; Melita Peric Balja; Karmen Bilic
Journal:  J Transl Med       Date:  2020-12-11       Impact factor: 5.531

8.  Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors.

Authors:  G Weiss; C Lai; M E Fife; A M Grabiec; B Tildy; R J Snelgrove; G Xin; C M Lloyd; T Hussell
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

9.  N-terminomics identifies widespread endoproteolysis and novel methionine excision in a genome-reduced bacterial pathogen.

Authors:  Iain J Berry; Veronica M Jarocki; Jessica L Tacchi; Benjamin B A Raymond; Michael Widjaja; Matthew P Padula; Steven P Djordjevic
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.